Finished
Safety and Effectiveness of Robotic-Assisted Remote Surgery for Breast Tumors
NCT07850323 · Guangzhou Women and Children's Medical Center · Updated 30 Sept 2026
- What is being tested
- Robotic-assisted axillary lymph node dissection; Robotic-assisted axillary lymph node dissection
- For
- Breast Neoplasms
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 85 years. About 25 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 1 Aug 2026, ends 1 Aug 2026. Registered 30 Sept 2026.
- Results
- None posted yet.
In the researchers' words
This is a multicenter retrospective clinical study. The research aims to explore the safety and efficacy of robotic single-port thoracoscopic minimally invasive surgery for breast cancer patients. Patients receiving robotic single-port thoracoscopic surgery for breast tumors will be enrolled. We will collect perioperative indicators, postoperative complications and follow-up data to compare clinical outcomes, so as to provide evidence for the clinical application of remote robotic single-port thoracoscopic surgical technology in breast oncology.
Sites
- Guangzhou Women and Children's Medical Center, Guangzhou Medical UniversityGuangzhou, Guangdong, China